Clinical Trial Update: Fluoxetine as a Quit Smoking AID for Depression Prone [NA]

View source ↗

Summary

This clinical trial update reports that a study evaluating fluoxetine as a quit-smoking aid for individuals prone to depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Disease

Drugs mentioned

• Fluoxetine (Prozac) (Fluoxetine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | NA | Status: COMPLETED